Open original FDA record ↗Recall record
- FDA identifier
- Z-1528-2014
- Company in FDA record
- INO Therapeutics (dba Ikaria)
- FDA classification date
- May 2, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
An anomaly impacts the monitoring system of INOmax DSIR Plus (software 3.0.0). When the integrated pneumatic backup switch is activated with low or no gas flow through the injector module, an intended NO cell failure alarm will occur. In addition, an unintended NO2 cell failure alarm may also occur. The NO/NO2 cell failure alarms are caused by an average NO/NO2 circuit concentration greater tha
Source facts
- Action
- Ikaria sent an Urgent Field Corrective Action letter via FedEx on March 27, 2014. The letter identified the issue, and requested that all INOmax DSIR with software version 3.0.0 be returned to Ikaria. Customers with questions were instructed to contact Ikaria Customer Care at 1-877-566-9466. For questions regarding this recall call 877-566-9466.
- Initiated
- 2014-03-27
- Root cause
- Software Design Change
- Terminated
- 2014-11-21
- Distribution
- Nationwide Distribution including DC and VA.
- Recall number
- Z-1528-2014
- Recall status
- Terminated
- CDRH record ID
- 126644
- FDA classified
- 2014-05-02
- Recall event number
- 67947